Janus Henderson VIT Balanced Instl Fund (JABLX - Free Report) seeks long-term appreciation of capital. JABLX primarily invests up to 65% of its assets in equity securities and the rest of its assets are invested in fixed-income securities and cash equivalents. JABLX may also invest about one-fourth of its assets in fixed income senior securities. JABLX may also invest in foreign issuers, particularly in emerging markets.
This Allocation Balanced producthas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 7.1% and 5 year almost 9.9%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
JABLX’s performance, as of the last filing, when compared to funds in its category was in the top 2% over the past 1 year, and in the top 13% over the past 3 years and in the top 9% over the past 5 years.
The Janus Henderson VIT Balanced Instl Fund, as of the last filing, allocates their fund in top two major groups; Intermediate Bond and Large Growth. Further, as of the last filing, Microsoft Corp, Mastercard Inc A and Boeing Co were the top holdings for JABLX.
This Zacks Rank #1 (Strong Buy) was incepted in September 1993 and is managed by Janus Fund. JABLX carries an expense ratio of 0.64% and requires a minimal initial investment of $0.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Janus Henderson VIT Balanced Instl Fund (JABLX - Free Report) seeks long-term appreciation of capital. JABLX primarily invests up to 65% of its assets in equity securities and the rest of its assets are invested in fixed-income securities and cash equivalents. JABLX may also invest about one-fourth of its assets in fixed income senior securities. JABLX may also invest in foreign issuers, particularly in emerging markets.
This Allocation Balanced producthas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 7.1% and 5 year almost 9.9%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
JABLX’s performance, as of the last filing, when compared to funds in its category was in the top 2% over the past 1 year, and in the top 13% over the past 3 years and in the top 9% over the past 5 years.
The Janus Henderson VIT Balanced Instl Fund, as of the last filing, allocates their fund in top two major groups; Intermediate Bond and Large Growth. Further, as of the last filing, Microsoft Corp, Mastercard Inc A and Boeing Co were the top holdings for JABLX.
This Zacks Rank #1 (Strong Buy) was incepted in September 1993 and is managed by Janus Fund. JABLX carries an expense ratio of 0.64% and requires a minimal initial investment of $0.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on JABLX - FREE